Schizophrenia is a common mental disorder with a complex pattern of inheritance. Despite a large number of studies in the past decades, its molecular etiology remains unknown. In this study, we proposed a 'system-thinking' strategy in seeking the combined effect of susceptibility genes for a complex disorder by using paranoid schizophrenia as an example. We genotyped 85 reported single-nucleotide polymorphisms (SNPs) present in 23 genes for the dopamine (DA) metabolism pathway among 83 paranoid schizophrenics and 108 normal controls with detailed clinical and genetic information. We developed two novel multilocus approaches - the potential effective SNP combination pattern and potential effective dynamic effects analysis, by which...
Over 100 loci are now associated with schizophrenia risk as identified by single nucleotide polymorp...
Objective. The authors used a genome-wide association study (GWAS) of multiply affected families to ...
BackgroundA significant portion of patients with schizophrenia who respond to initial antipsychotic ...
Aim: We investigated 16 polymorphisms from three genes, dopamine receptor D2 (DRD2), catechol-O-meth...
We evaluated the hypothesis that dopaminergic polymorphisms are risk factors for schizophrenia (SZ)....
1. Schizophrenia is a chronic, disabling brain disease that affects approxmately 1% of the world's p...
Schizophrenia affects one percent of the population and has life-long debilitating consequences for ...
Objective: The authors sought to demonstrate that schizophrenia is a heterogeneous group of heritabl...
The susceptibility to common psychiatric disorders is largely determined by genetic factors. Knowled...
Schizophrenia (SZ) is an inheritable complex mental disease. There have been several genome-wide ass...
Schizophrenia is a complex disorder, caused by both genetic and environmental factors and their inte...
Dysfunctions of glutamatergic and GABAergic neurotransmission are two important hypotheses for the p...
To access publisher full text version of this article. Please click on the hyperlink in Additional L...
The dopamine hypothesis of schizophrenia (SZ) has moti-vated a large number of genetic association s...
Genome-wide association studies (GWAS) have identified a large number of gene variants associated wi...
Over 100 loci are now associated with schizophrenia risk as identified by single nucleotide polymorp...
Objective. The authors used a genome-wide association study (GWAS) of multiply affected families to ...
BackgroundA significant portion of patients with schizophrenia who respond to initial antipsychotic ...
Aim: We investigated 16 polymorphisms from three genes, dopamine receptor D2 (DRD2), catechol-O-meth...
We evaluated the hypothesis that dopaminergic polymorphisms are risk factors for schizophrenia (SZ)....
1. Schizophrenia is a chronic, disabling brain disease that affects approxmately 1% of the world's p...
Schizophrenia affects one percent of the population and has life-long debilitating consequences for ...
Objective: The authors sought to demonstrate that schizophrenia is a heterogeneous group of heritabl...
The susceptibility to common psychiatric disorders is largely determined by genetic factors. Knowled...
Schizophrenia (SZ) is an inheritable complex mental disease. There have been several genome-wide ass...
Schizophrenia is a complex disorder, caused by both genetic and environmental factors and their inte...
Dysfunctions of glutamatergic and GABAergic neurotransmission are two important hypotheses for the p...
To access publisher full text version of this article. Please click on the hyperlink in Additional L...
The dopamine hypothesis of schizophrenia (SZ) has moti-vated a large number of genetic association s...
Genome-wide association studies (GWAS) have identified a large number of gene variants associated wi...
Over 100 loci are now associated with schizophrenia risk as identified by single nucleotide polymorp...
Objective. The authors used a genome-wide association study (GWAS) of multiply affected families to ...
BackgroundA significant portion of patients with schizophrenia who respond to initial antipsychotic ...